Speaking at the inaugural session of the “Global Online Conference on Combating Covid-19: Biotech to the Rescue” organised by Bennett University, she said the country has risen to the occasion and has shown its capability to develop test kits.
“India has arisen to the occasion with indigenous kits to face the challenge of the insufficient availability of diagnostic kits,” she said.
Kiran said India should also begin manufacturing components of the test kits besides assembling them. She also highlighted that scientists are working to develop serological tests and vaccines.
Shahid Jameel, CEO of Wellcome Trust DBT India Alliance, said, “There are two very large trials happening across the world to test the efficacy of drugs including WHO solidarity trial which is being done in multiple countries including India which will test Remdesivir, protease inhibitors, combination of some of these with interference of beta and it will also test hydroxychloroquine.”
“The second trial is funded by Wellcome Trust, Gates Foundation and Master Card. This is called an accelerated trial which will look at the efficacy of Hydroxychloroquine,” he added.